THE APEX TIMES
DBV Technologies CEO to Take Part in Goldman Sachs Global Healthcare Fireside Chat on June 9
DBV Technologies says Daniel Tassé will join a fireside chat at the Goldman Sachs 47th Annual Global Healthcare Conference, with a live webcast and an archived replay available for 90 days.
Châtillon, France-based DBV Technologies said its chief executive, Daniel Tassé, will participate in a fireside chat at the Goldman Sachs 47th Annual Global Healthcare Conference on Tuesday, June 9, 2026, at 9:20 a.m. Eastern time in Miami, Florida.
The company said the fireside chat will be webcast live and that an archived replay will be available for 90 days after the event, with the session listed on DBV’s investor-events page under upcoming events for June 9, 2026.
DBV Technologies describes itself as a late-stage biopharmaceutical company focused on food allergies and other immunologic conditions with significant unmet medical need. Its core approach centers on VIASKIN, an over-the-skin (epicutaneous) patch intended to deliver very small quantities of biologically active compounds to the immune system.
The company’s materials explain that its epicutaneous immunotherapy program, known as EPIT, is designed to introduce microgram amounts of a compound through intact skin. DBV says the goal is to help modify an underlying allergy by “re-educating” the immune system, with the patch meant to drive desensitization to an allergen.
DBV also outlined the broader platform context behind the upcoming conference engagement. In its description of ongoing programs, the company said it is investigating VIASKIN patch technology for food allergies, and it referenced clinical trials for VIASKIN Peanut in peanut-allergic children, including toddlers aged 1 to 3 and children aged 4 to 7.
For investors, the practical significance of such conference participation is that it can provide management an opportunity to address investor questions on strategy, timelines, and clinical or regulatory planning without the formal structure of a quarterly earnings call. In DBV’s case, however, the announcement itself does not specify what topics will be covered in the fireside chat.
DBV did not provide any additional clinical or financial data in the announcement. It did not disclose a detailed agenda, expected Q&A themes, or any guidance updates tied to the conference, beyond indicating that the webcast will be accessible live and replayed for 90 days.
Why It Matters
- Management participation in major healthcare conferences is often used to reinforce strategy and respond to investor questions, particularly for clinical-stage and late-stage biopharma companies.
- For DBV, the fireside chat timing in early June places it close to mid-year investor planning, which can shape how shareholders interpret near-term milestones.
- Because the announcement includes webcast and replay access but limited substantive new information, the main value may be Q&A rather than new disclosed results.
- Investors will likely watch for any management commentary on clinical development momentum and regulatory expectations, even though the company did not specify those topics in advance.
Sources
Key Facts
- DBV Technologies said CEO Daniel Tassé will participate in a fireside chat at the Goldman Sachs 47th Annual Global Healthcare Conference on Tuesday, June 9, 2026, at 9:20 a.m. Eastern time.
- The event is scheduled in Miami, Florida, according to DBV’s announcement.
- DBV stated the fireside chat will be available via a live webcast and an archived replay for 90 days after the event.
- DBV described itself as a late-stage biopharmaceutical company focused on food allergies and other immunologic conditions with unmet medical need.
- The company’s approach centers on VIASKIN patch technology and EPIT, which DBV describes as epicutaneous immunotherapy delivering microgram amounts through intact skin.
- DBV said it has ongoing clinical trials of VIASKIN Peanut in peanut-allergic toddlers (1 to 3 years old) and children (4 to 7 years old).
Finance Related
Bank of America points to a shift in how gold is being positioned, Yahoo Finance reports
A Yahoo Finance market update says Bank of America has identified signs of a broader change in gold positioning, drawing attention from investors monitoring bullion trends.
KKR’s “mini Berkshire” push shows early results as it sells USI assets for about $17 billion
KKR said it has completed a major first step in its Strategic Holdings effort that aims to emulate Berkshire Hathaway’s long-term approach, including an initial large exit tied to U.S. insurance investments. The deal size, reported at roughly $17 billion, marks one of the first sizable realizations from the portfolio concept.
Berkshire Hathaway shares appear less expensive than a conservative earnings-based valuation, analysis says
A market-focused valuation review points to continued upside based on earnings-driven assumptions, even after Berkshire Hathaway’s shares have already surged over the past five years.
JPMorgan Chase issues long-dated callable notes while expanding its retail footprint, according to market commentary
A Yahoo Finance market note pointed to JPMorgan Chase & Co.’s recent slate of callable, unsecured medium-term notes spanning 2031 through 2056, alongside a new retail branch effort, as investors weigh the implications for funding and capital returns.
GRAIL schedules conference appearance at Morgan Stanley’s 24th Global Healthcare event
The cancer-detection company said its management team will present at Morgan Stanley’s annual healthcare conference, an event investors commonly use to gauge updates across the biotech and diagnostics sector.
Goldman Sachs buys into high-income ETF, spotlighting the tradeoffs behind covered-call payouts
A newly reported Goldman Sachs purchase of the $13 billion QQQI covered-call ETF draws attention to the compromise investors may be making when they chase monthly income tied to the Nasdaq-100.
HubSpot CEO Yamini Rangan scheduled to present at Goldman Sachs Communacopia + Technology Conference
HubSpot said its chief executive, Yamini Rangan, is slated to speak at the Goldman Sachs Communacopia + Technology Conference, bringing investor attention to the company’s platform strategy for businesses and marketing teams.
Chewy to send CEO Sumit Singh to Goldman Sachs Global Consumer and Retail Conference 2026
Pet retailer Chewy said CEO Sumit Singh will participate in the Goldman Sachs Global Consumer and Retail Conference in 2026, indicating continued investor engagement with the consumer and retail sector.
Coinbase expands partnership with Webull in Canada, positioning crypto trading for a wider user base
A reported update says Coinbase has broadened its collaboration with online broker Webull to serve customers in Canada, though the companies have not detailed commercial terms in the announcement.
Visa Joins Mastercard and Fiserv in Group Aiming to Set Rules for AI Agent Payments
A new industry initiative, the Agentic Payments Alliance, is bringing card networks, a payments processor, and partners together to align on how payments by AI “agents” should work.
